Healthy diet may reduce cognitive decline as people age

by Karolinska InstitutetEating healthier may reduce cognitive decline and diminish the negative impact of an unhealthy diet on memory and thinking abilities in older adults, suggests a new study

Updated on: February 26,2024

Healthy diet may reduce cognitive decline as people age

by Karolinska InstitutetEating healthier may reduce cognitive decline and diminish the negative impact of an unhealthy diet on memory and thinking abilities in older adults, suggests a new study

Updated on:February 26,2024

Insurers balk at paying for Biogen's $56,000-a-year Alzheimer's treatment

by John Tozzi, Angelica Lavito and Anushree DaveCredit: CC0 Public DomainU.S. health insurers say they want more proof before paying for Biogen Inc.'s Aduhelm, stalling sales of the costly new Alz

Updated on: April 29,2024

Insurers balk at paying for Biogen's $56,000-a-year Alzheimer's treatment

by John Tozzi, Angelica Lavito and Anushree DaveCredit: CC0 Public DomainU.S. health insurers say they want more proof before paying for Biogen Inc.'s Aduhelm, stalling sales of the costly new Alz

Updated on:April 29,2024

Dementia risk scores have high error rates

by Lori SolomonCurrent dementia risk scores have high error rates and limited clinical utility for estimating 10-year risk, according to a study published online June 13 inJAMA Network Open.Mika

Updated on: May 06,2024

Dementia risk scores have high error rates

by Lori SolomonCurrent dementia risk scores have high error rates and limited clinical utility for estimating 10-year risk, according to a study published online June 13 inJAMA Network Open.Mika

Updated on:May 06,2024

Different biological variants discovered in Alzheimer's disease

by Amsterdam University Medical CenterCredit: Pixabay/CC0 Public DomainDutch scientists have discovered five biological variants of Alzheimer's disease, which may require different treatments. As

Updated on: February 24,2024

Different biological variants discovered in Alzheimer's disease

by Amsterdam University Medical CenterCredit: Pixabay/CC0 Public DomainDutch scientists have discovered five biological variants of Alzheimer's disease, which may require different treatments. As

Updated on:February 24,2024

Case study showcases effectiveness of multimodality approaches for diagnosing hydrocephalus

by Beijing Institute of Technology Press Co., LtdThis case demonstrates the efficacy of using multimodality approaches for iNPH diagnosis, which saves the patient time and clinical costs, worthy of fu

Updated on: September 05,2024

Case study showcases effectiveness of multimodality approaches for diagnosing hydrocephalus

by Beijing Institute of Technology Press Co., LtdThis case demonstrates the efficacy of using multimodality approaches for iNPH diagnosis, which saves the patient time and clinical costs, worthy of fu

Updated on:September 05,2024

Resveratrol appears to restore blood-brain barrier integrity in Alzheimer's disease

by Georgetown University Medical CenterSkeletal formula of trans-resveratrol. Image: WikipediaResveratrol, given to Alzheimer's patients, appears to restore the integrity of the blood-brain b

Updated on: March 09,2024

Resveratrol appears to restore blood-brain barrier integrity in Alzheimer's disease

by Georgetown University Medical CenterSkeletal formula of trans-resveratrol. Image: WikipediaResveratrol, given to Alzheimer's patients, appears to restore the integrity of the blood-brain b

Updated on:March 09,2024

Gene ID'd as potential therapeutic target for dementia in Parkinson's

by Washington University School of MedicineClumps of the Parkinson's protein alpha-synuclein (red) are visible inside neurons (green) in the brain of a mouse. Researchers at Washington Univer

Updated on: June 14,2024

Gene ID'd as potential therapeutic target for dementia in Parkinson's

by Washington University School of MedicineClumps of the Parkinson's protein alpha-synuclein (red) are visible inside neurons (green) in the brain of a mouse. Researchers at Washington Univer

Updated on:June 14,2024

AI reveals new insights into human brain activity

byFriedrich–Alexander University Erlangen–NurnbergTuning curve: a: LFP stream of 3 electrodes (shades of blue) during 50 ms pure tone stimuli (pure tone intensity: 110 dB SPL−70 dB SPL, frequenc

Updated on: September 23,2024

AI reveals new insights into human brain activity

byFriedrich–Alexander University Erlangen–NurnbergTuning curve: a: LFP stream of 3 electrodes (shades of blue) during 50 ms pure tone stimuli (pure tone intensity: 110 dB SPL−70 dB SPL, frequenc

Updated on:September 23,2024

Alzheimer 'tau' protein far surpasses amyloid in predicting toll on brain tissue

by University of California, San FranciscoPET scan of a human brain with Alzheimer's disease. Credit: public domainBrain imaging of pathological tau-protein "tangles" reliably predi

Updated on: April 02,2024

Alzheimer 'tau' protein far surpasses amyloid in predicting toll on brain tissue

by University of California, San FranciscoPET scan of a human brain with Alzheimer's disease. Credit: public domainBrain imaging of pathological tau-protein "tangles" reliably predi

Updated on:April 02,2024

Improved fitness can mean living longer without dementia

by Norwegian University of Science and TechnologyCredit: AI-generated imageStaying fit or improving fitness over time should be a goal for anyone who wants to reduce the likelihood of getting dem

Updated on: June 24,2024

Improved fitness can mean living longer without dementia

by Norwegian University of Science and TechnologyCredit: AI-generated imageStaying fit or improving fitness over time should be a goal for anyone who wants to reduce the likelihood of getting dem

Updated on:June 24,2024

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on: April 16,2024

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on:April 16,2024

Models show promise in predicting cognitive decline in early Alzheimer's

byAmerican Academy of NeurologyCredit: Pixabay/CC0 Public DomainA new study, published in the July 10 online issue ofNeurology, looks at predicting how quickly people with early Alzheimer&

Updated on: July 11,2024

Models show promise in predicting cognitive decline in early Alzheimer's

byAmerican Academy of NeurologyCredit: Pixabay/CC0 Public DomainA new study, published in the July 10 online issue ofNeurology, looks at predicting how quickly people with early Alzheimer&

Updated on:July 11,2024